| Medis Technologies
Ltd. (NASDAQ:MDTL) announced today that its refuelable fuel cell Power
Packs, developed to power an Itronix(R) Corporation tablet (GoBook(TM))
under a contract with General Dynamics with funding from the U.S. Air Force,
performed successfully in meeting the specified test criteria. The Power
Pack produces eight watts at 5.0 volts output and when depleted of its
fuel can be refueled by a fuel cartridge in a matter of seconds.
"This fuel cell power pack, which
we developed for use with the Itronix GoBook(TM) funded by the Air Force,
demonstrates the breadth of our technology to deliver much greater power
- more than six times the watts - than oour disposable power pack for cell
phones and other portable devices," said Robert K. Lifton, Chairman and
CEO of Medis Technologies. "It also demonstrates our ability to produce
a refuelable fuel cell using a refueling cartridge as compared with our
disposable product.
I should note, too, that we were
pleased with the announcement by General Dynamics of its agreement to acquire
Itronix, since that provides us with the opportunity to work even more
closely with General Dynamics C4 Systems on tablets and other portable
devices developed by Itronix for the military and industrial markets they
intend to access.
During August our marketing team
has met with U.S. and U.K. mobile operators and OEMs demonstrating the
new iteration of our disposable commercial Power Pack, and meetings are
scheduled to continue in the U.S. and Europe well into September. The responses
from those meetings held thus far, have reinforced my personal conviction
that this product will have considerable acceptance in the market place.
While this latest iteration of the disposable power pack already is small
enough to fit into a shirt pocket, we expect that the final version will
be even smaller and offer more attractive design features (see the design
contest information at www.medistechnologies.com). The final version is
scheduled for delivery to our potential customers for their laboratory
testing during the next quarter. We continue on plan to have the semi-automated
line capable of producing 10,000 to 20,000 Power Packs per month up at
the end of this year with customer deliveries expected in the first quarter
of 2006. We are also on schedule for placing the order for the automated
line capable of 1.5 million units a month in the next few weeks.
As previously announced, we already
have orders from one distributor, ASE International, for 200,000 Power
Packs a month for the first year of production from the planned automated
line which represents fifteen percent of that line's expected production
capacity, and our target is to have the entire line capacity sold out before
construction of the line is completed so that we can start on a second
automated line as soon as possible."
Medis will be presenting at three
upcoming investor conferences in September where the Company plans to demonstrate
its commercial Power Pack charging a broad number of devices, including
cell phones, smart phones, PDA's and electronic games. These conferences
are: The Roth Capital Partners New York Conference in New York City on
September 7th; the ThinkEquity Partners 3rd Annual Growth Conference in
San Francisco on September 14th; and the Merriman Curhan Ford & Co.
Investor Summit in San Francisco on September 19th.
Medis Technologies' primary focus
is on direct liquid fuel cell technology. Its business strategy is to sell
its products to end users through retail outlets and service providers.
Medis has also developed the CellScan with many potential applications
relating to disease diagnostics and chemo sensitivity. Additionally, Medis'
product pipeline includes other technologies, in varying stages of development.
This press release may contain forward-looking
statements, which are made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. Such forward-looking
statements involve risk and uncertainties, including, but not limited to,
the successful completion of product development, the success of product
tests, commercialization risks, availability of financing and results of
financing efforts. Further information regarding these and other risks
is described from time to time in the Company's filings with the SEC.
~

|